Post by
Idvhmz123 on Mar 31, 2021 9:12am
DELC.TO News Release - GREAT NEWS
Delic's Acquisition Target, Complex Biotech Discovery Ventures Ltd., Receives First Research Orders Through Online Payment Platform Canada NewsWire VANCOUVER, BC, March 31, 2021 After recently launching its Advanced Analytical Testing services, CBDV successfully receives orders through their new online payment platform VANCOUVER, BC, March 31, 2021 /CNW/ - Delic Holdings Inc. (the "Company"), ("DELIC") (CSE: DELC) (OTCQB: DELCF), a psychedelic focused wellness company, is pleased to announce that its acquisition target, Complex Biotech Discovery Ventures Ltd. ("CBDV"), a licensed cannabis and psilocybin research laboratory specializing in chemical analytics, extraction optimization, and process design, has commercialized and received its first research orders for Advanced Analytical Testing services through CBDV's new online payment platform. Matt Stang, CEO and Co founder commented "CBDV has shown they have the foresight to see what is needed in industries before it is normal practice. We expect to see the same professional expertise they show in cannabis, in this new psychedelic industry. This is another milestone that shows our commitment to increasing shareholder value." CBDV recently launched its Advanced Analytical Testing service which offers a streamlined process that allows clients to conveniently order tests online and ship their samples directly to CBDV's lab. Clients can choose from a wide range of tests that provide a comprehensive analysis on cannabis flower, concentrates, formulations, and vapor/smoke. Chief Executive Officer, Dr. Markus Roggen, stated: "We saw the need for chemical analytics beyond compliant testing to enable producers to develop the next generation of cannabis products. Therefore, we wanted to bring the high precision tools we are using in our own research directly to Canadian producers. And to enable an efficient customer experience, while giving us a scalable platform, we put a lot of effort into this webstore." With access to facilities at the University of British Columbia, CBDV uses industry-leading instrumentation and chemical expertise to provide clients with a thorough analysis of their cannabis samples. Clients receive an in-depth and precise characterization of their materials throughout each stage of the product development process. The tests offered go beyond the basic compliance testing for product releases required by Health Canada. CBDV's variety of tests include smoke analysis, NMR spectroscopy, X-ray crystallography, high resolution mass spectroscopy and many more that can be ordered directly on CBDV's website. For more information on the transaction between the Company and CBDV, please refer to the news release of the Company dated February 25, 2021